Page last updated: 2024-08-24

atorvastatin and daptomycin

atorvastatin has been researched along with daptomycin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Asada, M; Bando, T; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kondo, Y; Miyata, K; Nakamoto, A; Niimura, T; Okada, N; Takechi, K; Tasaki, Y; Yagi, K; Yanagawa, H; Yoshioka, T; Zamami, Y	1

Reviews

1 review(s) available for atorvastatin and daptomycin

Article	Year
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-12, Volume: 75, Issue:8 Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Daptomycin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; United States; United States Food and Drug Administration	2022

Article

Year

Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-12, Volume: 75, Issue:8

Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Daptomycin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; United States; United States Food and Drug Administration

2022